A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

1993 • 14,121 citations

Reporting results of cancer treatment

1981 • 7,916 citations

Analysis of Survival Data

1984 • 6,206 citations

Analysis of Survival Data.

1985 • 4,374 citations

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.

1992 • 1,198 citations

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.

1989 • 781 citations

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.

1993 • 661 citations

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases

1994 • 538 citations

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.

1995 • 365 citations

Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial.

1992 • 344 citations

Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry.

1989 • 286 citations

Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses

1993 • 212 citations

Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer

1994 • 193 citations

Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project.

1994 • 188 citations

Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.

1985 • 155 citations

Phase III Study of Bolus Versus Infusion Fluorouracil With or Without Cisplatin in Advanced Colorectal Cancer

1996 • 132 citations

Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU.A southwest oncology group study

1976 • 110 citations

Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C

1979 • 86 citations

Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer.

1995 • 83 citations

Mitomycin C Therapy in Advanced Gastrointestinal Cancer

1968 • 69 citations

Chemotherapy for metastatic colorectal cancer

1992 • 57 citations

5FU infusion with mitomycin-C versus 5FU infusion with methyl-CCNU in the treatment of advanced colon cancer.A southwest oncology group study

1978 • 53 citations

Clinical experience with mitomycin C in large infrequent doses

1972 • 49 citations

A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome

1993 • 48 citations

The synergistic anti-neoplastic activity of combinations of mitomycins with either 6-thioguanine or 5-fluorouracil.

1965 • 44 citations

Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer

1994 • 38 citations

Effects of mitomycin c (NSC-26980) in 346 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.

1968 • 36 citations

Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.

1986 • 31 citations

Mitomycin‐C alone and in combination with infused 5‐fluorouracil in the treatment of disseminated gastrointestinal carcinomas

1978 • 25 citations

Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer

1995 • 19 citations

Clinical study of mitomycin C (NSC-26980) in colorectal cancer.

1969 • 6 citations

Cited By (0)

Loading...